AAAAAA
Results:
1-10
|
Results: 10
Authors:
LOGAN TF
GOODING WE
WHITESIDE TL
ERNSTOFF MS
KAPLAN SS
MIKETIC L
VLOCK DR
TOMPKINS C
WOOD DL
NADLER PI
KIRKWOOD JM
Citation: Tf. Logan et al., BIOLOGIC RESPONSE MODULATION BY TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) IN A PHASE IB TRIAL IN CANCER-PATIENTS, Journal of immunotherapy with emphasis on tumor immunology, 20(5), 1997, pp. 387-398
Authors:
VLOCK DR
ANDERSEN J
KALISH LA
JOHNSON JT
KIRKWOOD JM
WHITESIDE T
HERBERMAN RB
ADAMS GS
OKEN MM
HASELOW RE
Citation: Dr. Vlock et al., PHASE-II TRIAL OF INTERFERON-ALPHA IN LOCALLY RECURRENT OR METASTATICSQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK - IMMUNOLOGICAL AND CLINICAL CORRELATES, Journal of immunotherapy with emphasis on tumor immunology, 19(6), 1996, pp. 433-442
Authors:
VLOCK DR
SNYDERMAN CH
JOHNSON JT
MYERS EN
EIBLING DE
RUBIN JS
KIRKWOOD JM
DUTCHER JP
ADAMS GL
Citation: Dr. Vlock et al., PHASE IB TRIAL OF THE EFFECT OF PERITUMORAL AND INTRANODAL INJECTIONSOF INTERLEUKIN-2 IN PATIENTS WITH ADVANCED SQUAMOUS-CELL CARCINOMA OFTHE HEAD AND NECK - AN EASTERN-COOPERATIVE-ONCOLOGY-GROUP TRIAL, Journal of immunotherapy with emphasis on tumor immunology, 15(2), 1994, pp. 134-139
Authors:
FISHER SG
SCHANTZ SP
VLOCK DR
WOLF GT
Citation: Sg. Fisher et al., PREDICTORS OF RESPONSE - NEW VERSUS OLD - REPLY, Journal of clinical oncology, 12(5), 1994, pp. 1102-1102
Authors:
CHANG MJ
YU WD
REYNO LM
MODZELEWSKI RA
EGORIN MJ
ERKMEN K
VLOCK DR
FURMANSKI P
JOHNSON CS
Citation: Mj. Chang et al., POTENTIATION BY INTERLEUKIN-1-ALPHA OF CISPLATIN AND CARBOPLATIN ANTITUMOR-ACTIVITY - SCHEDULE-DEPENDENT AND PHARMACOKINETIC EFFECTS IN THERIF-1 TUMOR-MODEL, Cancer research, 54(20), 1994, pp. 5380-5386
Authors:
VLOCK DR
SCHANTZ SP
FISHER SG
SAVAGE HE
CAREY TE
WOLF GT
Citation: Dr. Vlock et al., CLINICAL CORRELATES OF CIRCULATING IMMUNE-COMPLEXES AND ANTIBODY REACTIVITY IN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK, Journal of clinical oncology, 11(12), 1993, pp. 2427-2433
Authors:
JOHNSON CS
CHANG MJ
YU WD
MODZELEWSKI RA
GRANDIS JR
VLOCK DR
FURMANSKI P
Citation: Cs. Johnson et al., SYNERGISTIC ENHANCEMENT BY INTERLEUKIN-1-ALPHA OF CISPLATIN-MEDIATED ANTITUMOR-ACTIVITY IN RIF-1 TUMOR-BEARING C3H HEJ MICE/, Cancer chemotherapy and pharmacology, 32(5), 1993, pp. 339-346
Authors:
WHITESIDE TL
LETESSIER E
HIRABAYASHI H
VITOLO D
BRYANT J
BARNES L
SNYDERMAN C
JOHNSON JT
MYERS E
HERBERMAN RB
RUBIN J
KIRKWOOD JM
VLOCK DR
Citation: Tl. Whiteside et al., EVIDENCE FOR LOCAL AND SYSTEMIC ACTIVATION OF IMMUNE CELLS BY PERITUMORAL INJECTIONS OF INTERLEUKIN-2 IN PATIENTS WITH ADVANCED SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK, Cancer research, 53(23), 1993, pp. 5654-5662
Authors:
TOPOROWICZ A
GERSTEN DM
HEARING VJ
BROWN WE
VLOCK DR
Citation: A. Toporowicz et al., CROSS-REACTIVITY BETWEEN MURINE MELANOMA ANTIGEN-B700 AND A HUMAN MELANOMA-ASSOCIATED ANTIGEN (M-66) RECOGNIZED BY AUTOLOGOUS ANTIBODY EVIDENCE SUGGESTING SHARED EPITOPES, Biochimica et biophysica acta, 1182(1), 1993, pp. 51-56
Authors:
VLOCK DR
TOPOROWICZ A
ARNOLD B
AUL D
MCCOY JP
CAREY TE
BROWN WE
Citation: Dr. Vlock et al., ISOLATION AND PURIFICATION OF A SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK-ASSOCIATED ANTIGEN IDENTIFIED BY AUTOLOGOUS ANTIBODY, Biochimica et biophysica acta, 1181(2), 1993, pp. 174-182
Risultati:
1-10
|